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Abstract
Background: Total thoracoscopic and laparoscopic esophagectomy (TLE) has attracted attention with the advantage
of better operative field and minimal wound for the esophageal cancer. However, various severe complications are also
reported during the TLE such as cervical anastomotic leakage, chylothorax, and tracheal injury. The aim of this study
was to introduce a new optimized TLE procedure for the esophageal cancer and assess its safety and clinical effects.
Methods: We retrospectively collected the clinical data of 30 patients with esophageal cancer who underwent optimized
TLE procedures between January 2014 and December 2014. The optimized TLE procedures mainly include as follows: (1)
50 ml of sesame oil-milk mixture (1:1) is injected via gastric tube after endotracheal intubation; (2) patients are intubated
with a single lumen endotracheal tube; (3) patients were positioned at 150° in the left prone position rather than lateral
decubitus position; and (4) duodenal feeding tube was not placed intraoperatively and however triple lumen nasojejunal
feeding tube was placed on the second postoperative day under imaging guidance. Operation time, amount of blood
loss, number of dissected nodes, length of hospital stays, and complications were recorded.
Results: The mean operation time of the optimized TLE group was 202.13 ± 13.74 min. The mean visible blood
loss of the optimized TLE group was 300.00 ± 120.12 ml. The postoperative hospital stays in the optimized TLE
group were 16.27 ± 4.51 days. The number of dissected nodes in the optimized TLE group was 13.57 ± 2.76. The
postoperative complications for the optimized TLE procedure were seen in one case (3.3 %).
Conclusions: The method of optimized TLE is an effective, reliable, and safe procedure for the treatment of esophageal
cancer, which provide favorable outcomes in terms of operation time, blood loss, length of hospital stays, the number
the dissected nodes, and reduced incidence of postoperative complications compared to previous literatures. Further
studies with a large number of samples are warranted.
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Background
China has a high incidence of esophageal cancer, with a
mortality rate ranking fourth of all malignant tumors [1].
Esophageal resection is one of the primary therapeutic
methods for the esophageal cancer [2]. However, because
of the relatively high mortality and morbidity associated
with esophagectomy for esophageal cancer [3–5], there
have been many efforts to reduce its invasiveness [3, 6, 7].
Minimally invasive esophagectomy (MIE) has become in-
creasingly used and been accepted with reported outcomes
comparable with those of open approaches [8–13]. The
techniques used can be thoracoscopic, laparoscopic, or
both. As the experience and skills for thoracoscopic and
laparoscopic surgery improve, total thoracoscopic and lap-
aroscopic esophagectomy (TLE) has attracted more and
more attention with the advantage of better operative field
and minimal wound [14–18]. However, various severe
complications are also reported during the TLE such as
cervical anastomotic leakage, chylothorax, and tracheal in-
jury. Thus, how to avoid surgical risks and improve surgi-
cal efficiency further has become the focus. The aim of this
study was to introduce an optimized TLE procedure for
esophageal carcinoma and assess its safety and outcomes.
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The study was approved by the Ethics Committee of the
Hebei Provincial People’s Hospital and conducted in
accordance with the Declaration of Helsinki. Written in-
formed consent was obtained from all subjects. We retro-
spectively evaluated 30 patients with esophageal cancer
who underwent optimized thoracoscopic and laparoscopic
esophagectomy between January 2014 and December
2014. Histological diagnosis of esophageal cancers was
confirmed by esophagoscopy in all patients prior to sur-
gery. The inclusion criteria were (1) patients with clinical
stage I, II, and IIIa and IIIb esophageal cancer. The exclu-
sion criteria were (1) patients with clinical stage IIIc and IV
esophageal cancer; (2) patients with dyscrasia, or severe
heart, liver, brain, and kidney concomitants, (3) patient
who cannot subject one-lung ventilation due to poor lung
function, and (4) patients have history of thoracic and ab-
dominal surgery. The clinical characteristics of the 30 cases
were summarized in Table 1.
Preoperative evaluation
Preoperative work-up included blood routine examin-
ation, urine routine examination, blood biochemical test,
blood coagulation test, electrocardiogram, echocardiog-
raphy, chest and abdominal computed tomography (CT)
scans, endoscopic ultrasonography, positron emission
tomography-computed tomography (PET), upper gastro-
intestinal barium swallow, and pulmonary function test.
Surgical technique
The surgeries were performed by a group of three sur-
geons who have more than 15 years’ surgical experience.
Intrathoracic pressure of 8 mmHg and intraabdominal
pressures of 12 mmHg were used for thoracic and ab-
dominal surgery, respectively. The difference of conven-
tional procedure and our optimized procedures was as
follows:
During the conventional TLE procedure, the patient is
often intubated with a double lumen endotracheal tube
for single lung ventilation in the normal side and posi-
tioned in the left lateral decubitus position. The stomach
contents are aspirated to the greatest extent to empty
the stomach using a normal stomach tube before sur-
gery. Whereas during our optimized TLE group, the pa-
tient is intubated with a single lumen endotracheal tube
for bilateral lung ventilation and positioned in the prone
position with a 150° left lateral tilt. After endotracheal
intubation, 50 ml of sesame oil-milk mixture (1:1) is
injected via gastric tube.
The procedure was conducted in three stages. Firstly,
thoracoscopic dissection was done with the patient in
the left lateral decubitus position in conventional group
and prone position in the optimized group. Four thora-
coscopic ports are placed. The l2-mm camera port is
placed at the seventh intercostal space on the midaxil-
lary line. Two 5-mm ports (shaft handle’s hole) are
placed, one at the fifth intercostal space posterior to the
posterior axillary line and one at the fourth intercostal
space at the anterior axillary line. One additional 12-mm
port (assistant handle hole) is placed at the eighth inter-
costal space, posterior to the posterior axillary line. The
lung was retracted laterally using an atraumatic instru-
ment. Ultrasound knife or electrocautery was used to
separate the mediastinal pleura overlying the esophagus
to detect whether there exists the extra-esophagus inva-
sion such as thoracic aorta, membranous part of the tra-
chea, and left main bronchus. The azygos vein was
divided using Hemolok clips (Weck; Teleflex Medical,
Durham, NC, USA), and then the esophagus was cir-
cumferentially mobilized from the esophageal hiatus up
to the thoracic inlet. Paraesophageal lymph nodes were
dissected and removed or mobilized en bloc with the
resected specimen. Then complete hemostasis was per-
formed using hook electrode, and the chest cavity was
Table 1 Baseline characteristics
Optimized TLE procedure (n = 30)
Age (years), mean ± SD 65.63 ± 3.71
Sex
Male 21 (70 %)
Female 9 (30 %)
Comorbidity
Hypertension 3 (10 %)
Diabetes mellitus 2 (6.7 %)
COPD 1 (3.3 %)
Lacunar infarction 2 (6.7 %)
ASA score
1 2 (6.7 %)
2 28 (93.3 %)
pStage
I 2 (6.7 %)
IIa 4 (13.3 %)
IIb 6 (20.0 %)
IIIa 11 (36.7 %)
IIIb 7 (23.3 %)
Tumor location
Upper 16 (53.4 %)
Middle 13 (43.3 %)
Lower 1 (3.3 %)
Histology
Squamous carcinoma 28 (93.3 %)
Adenocarcinoma 2 (6.7 %)
ASA American Society of Anesthesiologists, COPD chronic obstructive
pulmonary disease
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flushed with normal saline. A 32F chest tube was
inserted through the camera port for postoperative chest
drainage.
In the second stage, the patient was placed in the supine
position. The surgeon stands on the patient’s right side and
the assistant on the left side. Five abdominal ports were
placed on the anterior abdominal wall. The l2-mm camera
port is placed at 1 cm superior to umbilicus. Two shaft
handle’s ports are placed (12- and 5-mm), one at 5 cm lat-
eral to the lateral border of the rectus abdominis muscle
and one at the junction between the right midclavicular
line and costal arch. Two additional 5-mm ports (assistant
handle hole) are placed, one at the epigastrium, approxi-
mately 3 cm below the xiphoid process and one at the
junction areas between the costal arch and the left anterior
axillary line. The operator stands on the right side of the
patients. After detecting the abdominal cavity, the entire
greater curvature of the stomach was mobilized, preserving
the right gastroepiploic vessels. The left gastroepiploic
artery, short gastric artery, and the peritoneum overlying
the abdominal esophagus were isolated and divided with
an ultrasound knife (HARMONIC ACE36E, Johnson &
Johnson, New Brunswick, NJ, USA). With a bowel forceps,
the left lobe of the liver is retracted upward to expose the
gastrohepatic ligaments and abdominal esophagus. The
lesser omentum was dissected with ultrasound knife. The
gastrohepatic ligament, the peritoneum overlying the ab-
dominal esophagus and the diaphragm’s esophageal hiatus,
was divided. Left gastric vessels overlying the pancreas su-
periorly were retracted with the endoscopic bowel forceps,
and then the two ends of left gastric vessels were clamped
and divided with ligature forceps. Lymph nodes around the
left gastric artery, splenic artery, and common hepatic ar-
tery were resected. After the bilateral crus of the dia-
phragm is exposed, the abdominal esophagus is retracted
to the abdominal cavity. The pneumoperitoneum was re-
moved, and incision below the xiphoid cardiac was ex-
panded approximately 3 cm. The gastric tube was then
created by dividing the stomach starting at the distal lesser
curve and ending at the cardiac notch (angle of His) using
the linear cutting staplers, preserving the right gastric ves-
sels. The gastric tube was then sutured to prevent twisting
and the mobilized esophagus for tunneling to the neck
using the interrupted seromuscular sutures.
In the third stage, a 4-cm horizontal neck incision is
made just above the suprasternal notch, and then the
cervical esophagus is exposed. The cervical esophagus is
divided, and the esophagogastric specimen was pulled
out of the abdomen incision. As traction is applied to
the specimen in the neck, another surgeon guides the
specimen in its proper alignment into the mediastinum.
The specimen is removed from the field. An anastomosis
is performed between the esophagus and gastric tube
with PROXIMATE ILS Curved and Straight Intraluminal
Staplers (Ethicon Endo-Surgery, LLC). The duodenal feed-
ing tube and stomach tube were placed across the anasto-
mosis. Fundus of the gastric tube was excised using a
linear cut stapler, and the margin was closed with inter-
rupted seromuscular suture in a figure-of-8 pattern using
non-absorbable Sutures Mersilk (braided silk).
Postoperative care
The differences of our optimized procedures and con-
ventional optimized procedures were as follows:
During conventional procedures, patients started naso-
gastric nutritional support with duodenal feeding tube and
gastrointestinal decompression with stomach tube on the
second postoperative day due to gastric emptying time
which is about 24–48 h after gastroenteric surgery. Oral
diet was started after duodenal feeding tube, and stomach
tube was removed on the fifth postoperative day.
During optimized group, patients started nasogastric nu-
tritional support with triple lumen nasojejunal feeding tube
(Freka-Trelumina; Fresenius, Bad Homberg, Germany) on
the second postoperative day. Distal intestinal feeding tube
was passed from pylorus to the jejunum through Treitz’s
ligament. Oral diet was started after triple lumen naso-
jejunal feeding tube was removed on the 10th postoper-
ative day.
Statistical analysis
Data analyses were performed using SPSS version 17.0
for windows (SPSS Inc., Chicago, IL, USA). All data are
expressed as the mean and standard deviation and num-
ber or percentage as appropriate.
Results
The patients consisted of 21 males and 9 females. The
mean age was 66 years (range, 56–72 years). The charac-
teristics of 30 patients undergoing optimized TLE for
esophageal cancer with regard to age, sex distributions,
incidence of comorbidities, tumor location, histology
except preoperative staging, and American Society of
Anesthesiologists (ASA) grade are shown in Table 1.
Surgical outcomes are shown in Table 2. The mean
total operation time for the optimized procedures was
202.13 ± 13.74 min. The mean blood loss was 300.00 ±
120.12 min. The postoperative hospital stays for the op-
timized procedures were 16.27 ± 4.51 days. The number
Table 2 Surgical outcomes of patients receiving optimized TLE
procedures
Optimized procedure (n = 30)
Operation time (min) 202.13 ± 13.74
Blood loss (ml) 300.00 ± 120.12
Length of hospital stay (days) 16.27 ± 4.51
Number of dissected nodes 13.57 ± 2.76
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of total lymph nodes removed was 13.57 ± 2.76 per pa-
tient in the optimized TLE group. Our perioperative out-
comes were slightly better compared with the previous
literatures [17–21].
With regard to the postoperative complications, the
cervical anastomotic leakage was seen in one case
(3.3 %) in our series. No other complications such as
chylothorax, tracheal fistula, recurrent laryngeal nerve
injury, and atelectasis were observed (Table 3). Our find-
ings were significantly lower than the previous litera-
tures [1, 14, 17, 18, 20–22].
Discussion
Thoracoscopic esophagectomy is currently accepted by
more and more thoracic surgeon due to minimal trauma
and rapid recovery [19]. With the recent advance in thora-
coscopic surgery, endoscopic esophagectomy gradually
modified from the endoscopic-assisted mini-incision to
total thoracoscopic and laparoscopic esophagectomy. This
modification helps to the decrease of the surgical time and
postoperative trauma [23]. However, with the number of
the operation increase, some complications which rarely
reported in the conventional three-port surgery also occur
because the operations are more complex than those re-
quired for other malignancies [18, 24–27]. After reviewing
the aforementioned literatures, we found the overall post-
operative complications following TLE can reach up to
about 47.6 % [17, 20, 28, 29]. Thus, how to reduce compli-
cations has become one issue that needs to be addressed
urgently. We analyzed the clinical data of cases undergoing
conventional TLE procedures in our hospital and found
that most of the patients develop tracheal fistula 4–14 days
after surgery when the gastric tube was removed and diet
was begun. We consider that it may be due to the strong
pressure difference between the negative intrathoracic and
positive intraabdominal pressure. In addition, bilateral
vagal neurectomy is liable to cause pyloric obstruction,
which may enhance the pressure difference. Optimized
TLE is a modification of conventional TLE, intended to di-
minish surgical trauma and decrease technical complica-
tions related to esophagectomy and associated lymph node
dissection and reconstruction of the gastrointestinal tract,
such as anastomotic leakage, recurrent laryngeal nerve
palsy (RLNP), and chylothorax. In the current study, we
optimized the protocols of the endoscopic esophagectomy.
Patients receiving optimized TLE started nasogastric nutri-
tional support with triple lumen nasojejunal feeding tube
on the second postoperative day. Tubular stomach was
maintained in a condition of negative pressure via cutting
multiple-side holes into the gastric tube lateral wall. Distal
intestinal feeding tube was passed from pylorus to the je-
junum throughTreitz’s ligament. Oral diet was started after
triple lumen nasojejunal feeding tube was removed on the
10th postoperative day. These procedures resolved the dif-
ficulties such as functional obstruction at the pylorus, nu-
tritional solution aggregation at the duodenum, and early
postoperative enteral nutrition, and meanwhile reduce the
surgical time. Our findings showed that the rate of postop-
erative complications in patients receiving the optimized
TLE procedures was 3.3 %, which significantly improved
compared to the previous reports.
In this study, patients in the optimized TLE group are
intubated with a single lumen endotracheal tube for bi-
lateral lung ventilation and positioned in the lateral
prone position. Through these procedures, the operative
field of the esophagus bed was similar in the conven-
tional and optimized TLE group under the application
of artificial pneumothorax. Due to the absence of two-
lumen endotracheal tubes cuffs, the membranous part of
the trachea is retrieved, which can clearly visualize
lymph around the recurrent laryngeal nerve in the left
side. In this study, patients treated with optimized TLE
did not develop any recurrent laryngeal nerve injury.
With regard to the number of retrieved total lymph
nodes collected, our study demonstrated slightly higher
number of lymph nodes dissected in the optimized TLE
group compared to the previous reports.
Thoracic duct injury is a rare but serious complication
following chest surgeries and major neck dissections,
which may lead to nutritional deficiencies, respiratory
dysfunction, and immunosuppression with a mortality
up to 50 % in untreated patients [30, 31]. Clinically, it
can present as cervical chylous fistula, chylothorax, or
chylopericardium. As reported, 60~70 % of fat intake
come together into cisterna chili via lymph vessels.
Enterogenous lymph has a clinical presentation of milky
white appearance due to a high content of triglycerides
and chylomicrons. The flow and the characteristics of
chyle from thoracic duct cannulae vary with the diet and
usually about 60–100 ml/h. This flow will increase obvi-
ously with a presentation of chyle appearance after feed-
ing (fat intake) and reduce with a presentation of clear
appearance under hungry or fasting conditions. Patients
should be fasted before the esophagectomy which go
against the intraoperative distinguishment of the thor-
acic duct injury due to the clear lymphatic fluid in the
thoracic duct. In the optimized TLE group, we infused the
Table 3 Postoperative complications of patients receiving
optimized TLE procedures
Optimized procedure (n = 30)
Postoperative complications 1 (3.3 %)
Cervical anastomotic leakage 1 (3.3 %)
Chylothorax 0
Tracheal fistula 0
Recurrent laryngeal nerve injury 0
Atelectasis 0
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triglyceride and protein-rich oil-milk mixtures via gastric
tube after tracheal intubation. Once the intraoperative
thoracic duct injury occurs, it will accompany white fluid
flow, which contributes to the prevention of the thoracic
duct injury. In this study, we found no thoracic duct injury
based on the above modifications of the TLE.
Conclusions
Optimized TLE is a safety and efficient surgical modality
for esophageal cancer, which provide favorable outcomes
in terms of operation time, blood loss, length of hospital
stays, the number the dissected nodes, and reduced inci-
dence of postoperative complications compared to previ-
ous literatures. Further studies with randomized controlled
trials are necessary for confirming the surgical efficacy of
our technique.
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